The association of serum prolidase activity and erectile dysfunction

Journal of Andrology

Volumn 31, Issue 2, 2010, Pages 146-154

  Savas, M ^a   Yeni, E ^a   Celik, H ^b   Ciftci, H ^a   Utangac, M ^a   Oncel, H ^a   Altunkol, A ^a   Verit, A ^a  

^a Medicine School of Harren University   (Turkey)

^b HARRAN UNIVERSITY   (Turkey)

Author keywords

Collagen turnover; Extracellular matrix; Oxidative stress

Indexed keywords

LIPID HYDROPEROXIDE; PROLINE DIPEPTIDASE;

ADULT; AGED; ARTICLE; ATHEROSCLEROTIC PLAQUE; COLLAGEN METABOLISM; DISEASE COURSE; DISEASE SEVERITY; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; ERECTILE DYSFUNCTION; EXTRACELLULAR MATRIX; HUMAN; INTERNATIONAL INDEX OF ERECTILE FUNCTION; MAJOR CLINICAL STUDY; MALE; MALE SEXUAL DYSFUNCTION; OXIDATIVE STRESS; PENILE BLOOD FLOW; PENIS ERECTION; PRIORITY JOURNAL; QUESTIONNAIRE; SCORING SYSTEM; SERUM; SPECTROPHOTOMETRY; VASCULAR ENDOTHELIUM;

ADULT; AGED; BIOLOGICAL MARKERS; DIPEPTIDASES; ERECTILE DYSFUNCTION; HUMANS; LIPID PEROXIDES; MALE; MIDDLE AGED; OXIDATIVE STRESS;

EID: 77950932088     PISSN: 01963635     EISSN: None     Source Type: Journal    
DOI: 10.2164/jandrol.109.008631     Document Type: Article

References (47)

1. Ahn TY, Gomez-Coronado D, Martinez V, Cuevas P, Goldstein I, Saenz de Tejada I. Enhanced contractility of rabbit corpus cavernosum smooth muscle by oxidized low density lipoproteins. Int J Impot Res. 1999;11:9-14. (Pubitemid 29090237)
2. Altindag O, Erel O, Aksoy N, Selek S, Celik H, Karaoglanoglu M. Increased oxidative stress and its relation with collagen metabolism in knee osteoarthritis. Rheumatol Int. 2007;27:339-344. (Pubitemid 46122276)
3. Arab K, Steghens JP. Plasma lipid hydroperoxides measurement by an automated xylenol orange method. Anal Biochem. 2004;325: 158-163. (Pubitemid 38050279)
4. Aronson D. Cross-linking of glycated collagen in the pathogenesis of arterial and myocardial stiffening of aging and diabetes. J Hypertens. 2003;21:3-12. (Pubitemid 36143498)
5. Asian M, Nazligul Y, Horoz M, Bolukbas C, Bolukbas FF, Aksoy N, Celik H, Erel O. Serum prolidase activity and oxidative status in Helicobacter pylori infection. Clin Biochem. 2007;40:37-40.
6. Cechowska-Pasko M, Palka J, Wojtukiewicz MZ. Enhanced prolidase activity and decreased collagen content in breast cancer tissue. Int J Exp Pathol. 2006;87:289-296. Chinard FP. Photometric estimation of proline and ornithine. J Biol Chem. 1952;199:91-95. Demirbag R, Yildiz A, Gur M, Yilmaz R, Elci K, Aksoy N. Serum prolidase activity in patients with hypertension and its relation with left ventricular hypertrophy. Clin Biochem. 2007;40:1020-1025. (Pubitemid 44049963)
7. Diez J. Arterial stiffness and extracellular matrix. Adv Cardiol. 2007;44:76-95.
8. Duong HS, Zhang QZ, Le AD, Kelly AP, Kamdar R, Messadi DV. Elevated prolidase activity in keloids: correlation with type I collagen turnover. Br J Dermatol. 2006;154:820-828.
9. Ellman GL. Tissue sulfhydryl groups. Arch Biochem Biophys. 1959;82:70-77.
10. Erbagci AB, Araz M, Erbagci A, Tarakcioglu M, Namiduru ES. Serum prolidase activity as a marker of osteoporosis in type 2 diabetes mellitus. Clin Biochem. 2002;35:263-268. (Pubitemid 34804895)
11. Evrenkaya TR, Atasoyu EM, Kara M, Unver S, Gultepe M. The role of prolidase activity in the diagnosis of uremic bone disease. Ren Fail. 2006;28:271-274. (Pubitemid 43977335)
12. Gejyo F, Kishore BK, Arakawa M. Prolidase and prolinase activities in the erythrocytes of patients with chronic uremia. Nephron. 1983;35:58-61. (Pubitemid 13069689)
13. Gensini GG. A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol. 1983;51:606-607.
14. Girotti AW. Lipid hydroperoxide generation, turnover, and effector action in biological systems. J Lipid Res. 1998;39:1529-1542.
15. Gonzalez-Cadavid NF. Mechanisms of penile fibrosis. J Sex Med. 2009;6(suppl 3):353-362.
16. Hu ML, Louie S, Cross CE, Motchnik P, Halliwell B. Antioxidant protection against hypochlorous acid in human plasma. J Lab Clin Med. 1993;121:257-262. (Pubitemid 23073132)
17. Izzo JL Jr, Mitchell GF. Aging and arterial structure-function relations. Adv Cardiol. 2007;44:19-34.
18. Kovanecz I, Nolazco G, Ferrini MG, Toblli JE, Heydarkhan S, Vernet D, Rajfer J, Gonzalez-Cadavid NF. Early onset of fibrosis within the arterial media in a rat model of type 2 diabetes mellitus with erectile dysfunction. BJU Int. 2009;103(10):1396-1404.
19. Lijnen HR. Metalloproteinases in development and progression of vascular disease. Pathophysiol Haemost Thromb. 20032004;33:275-281.
20. Liu G, Nakayama K, Awata S, Tang S, Kitaoka N, Manabe M, Kodama H. Prolidase isoenzymes in the rat: their organ distribution, developmental change and specific inhibitors. Pediatr Res. 2007;62:54-59. (Pubitemid 46985850)
21. Lue TF. Veno-occlusive dysfunction of corpora cavernosa: comparison of diagnostic methods. J Urol. 1996;155:786-787.
22. Luo H, Goldstein I, Udelson D. A three-dimensional theoretical model of the relationship between cavemosal expandability and percent cavernosal smooth muscle. J Sex Med. 2007;4:644-645. (Pubitemid 46779300)
23. Maas R, Schwedhelm E, Albsmeier J, Boger RH. The pathophysiology of erectile dysfunction related to endothelial dysfunction and mediators of vascular function. Vase Med. 2002;7:213-225. (Pubitemid 36104323)
24. Metro MJ, Broderick GA. Diabetes and vascular impotence: does insulin dependence increase the relative severity? Int J Impot Res. 1999;11:87-89.
25. Myara I, Charpentier C, Lemonnier A. Optimal conditions for prolidase assay by proline colorimetric determination: application to imminodipeptiduria. Clin Chim Acta. 1982;125:193-205. (Pubitemid 12002380)
26. Myara I, Myara A, Mangeot M, Fabre M, Charpentier C, Lemonnier A. Plasma prolidase activity: a possible index of collagen catabolism in chronic liver disease. Clin Chem. 1984;30:211-215. (Pubitemid 14190267)
27. Najjar SS, Scuteri A, Lakatta EG. Arterial aging: is it an immutable cardiovascular risk factor? Hypertension. 2005;46:454-462. (Pubitemid 41376818)
28. Nehra A, Goldstein I, Pabby A, Nugent M, Huang YH, de las Morenas A, Krane RJ, Udelson D, Saenz de Tejada I, Moreland RB. Mechanisms of venous leakage: a prospective clinicopathological correlation of corporeal function and structure. J Urol. 1996;156:1320-1329.
29. Newby AC, Southgate KM, Davies M. Extracellular matrix degrading metalloproteinases in the pathogenesis of arteriosclerosis. Basic Res Cardiol. 1994;89:59-70. (Pubitemid 24314598)
30. Palka JA, Phang JM. Prolidase activity in fibroblasts is regulated by interaction of extracellular matrix with cell surface integrin receptors. J Cell Biochem. 1997;67:166-175.
31. Rajfer J, Rosciszewski A, Mehringer M. Prevalence of corporal venous leakage in impotent men. J Urol. 1988;140:69-71.
32. Rubbo H, Trostchansky A, Botti H, Batthyany C. Interactions of nitric oxide and peroxynitrite with low-density lipoprotein. Biol Chem. 2002;383:547-552. (Pubitemid 34506290)
33. Schwartz EJ, Wong P, Graydon RJ. Sildenafil preserves intracorporeal smooth muscle after radical retropubic prostatectomy. J Urol. 2004;171:771-774. (Pubitemid 38090480)
34. Senboshi Y, Oono T, Arata J. Localization of prolidase gene expression in scar tissue using in situ hybridization. J Dermatol Sci. 1996;12:163-171. (Pubitemid 26201802)
35. Shah PK. Role of inflammation and metalloproteinases in plaque disruption and thrombosis. Vase Med. 1998;3:199-206.
36. Shrinath M, Walter JH, Haeney M, Couriel JM, Lewis MA, Herrick AL. Prolidase deficiency and systemic lupus erythematosus. Arch Dis Child. 1997;76:441-444. (Pubitemid 27261862)
37. Sienkiewicz P, Palka M, Palka J. Oxidative stress induces IGF-I receptor signaling disturbances in cultured human dermal fibroblasts. A possible mechanism for collagen biosynthesis inhibition. Cell Mol Biol Lett. 2004;9:643-650. (Pubitemid 40065190)
38. Singh R, Barden A, Mori T, Beilin L. Advanced glycation endproducts: a review. Diabetologia. 2001;44:129-146.
39. Solomon H, Man JW, Jackson G. Erectile dysfunction and the cardiovascular patient: endothelial dysfunction is the common denominator. Heart. 2003;89:251-253. (Pubitemid 36241528)
40. Surazynski A, Donald SP, Cooper SK, Whiteside MA, Salnikow K, Liu Y, Phang JM. Extracellular matrix and HIF-1 signaling: the role of prolidase. Int J Cancer. 2008;122:1435-1440. (Pubitemid 351287248)
41. Surazynski A, Sienkiewicz P, Wolczynski S, Palka J. Differential effects of echistatin and thrombin on collagen production and prolidase activity in human dermal fibroblasts and their possible implication in betal -integrinmedia ted signaling. Pharmacol Res. 2005;51:217-221. (Pubitemid 40127213)
42. Tal R, Voelzke BB, Land S, Motarjem P, Munarriz R, Goldstein I, Mulhall JP. Vasculogenic erectile dysfunction in teenagers: a 5-year multi-institutional experience. BJU Int. 2009;103(5):646-650.
43. Verit FF, Geyikli I, Yazgan P, Celik A. Correlations of serum prolidase activity between bone turnover markers and mineral density in postmenopausal osteoporosis. Arch Gynecol Obstet. 2006;274:133-137. (Pubitemid 43781417)
44. Wang YX, Fitch RM. Vascular stiffness: measurements, mechanisms and implications. Curr Vase Pharmacol. 2004;2:379-384. (Pubitemid 39200188)
45. Watanabe N, Ikeda U. Matrix metalloproteinases and atherosclerosis. Curr Atheroscler Rep. 2004;6:112-120.
46. Yildiz A, Demirbag R, Yilmaz R, Gur M, Altiparmak IH, Akyol S, Aksoy N, Ocak AR, Erel O. The association of serum prolidase activity with the presence and severity of coronary artery disease. Coron Artery Dis. 2008;19:319-325. (Pubitemid 351521110)
47. Zanaboni G, Dyne KM, Rossi A, Monafo V, Cetta G. Prolidase deficiency: biochemical study of erythrocyte and skin fibroblast prolidase activity in Italian patients. Haematologica. 1994; 79:13-18.